The value of plasma BNP and MCP-1 levels for short-term prognosis of UA without heart failure
DOI:
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To evaluate the early prognostic role of plasma brain natriuretic peptide(BNP)and monocyte chemoattractant protein-1(MCP-1)levels in patients with unstable angina(UA). Methods:Eighty-five cases UA without heart failure were divided into IB(n=25),IIB(n=30)and IIIB(n=30)groups according to Braunwald classification, and 20 cases stable angina pectoris(SAP)were chosen in the control group. Plasma samples for BNP and MCP-1 were obtained in the first 24 h. The incidences of main abnormal cardiac event(MACE)were recorded during 30 days. Results:In every UA groups,plasma levels of BNP and MCP-1 elevated significantly,and in comparison to those in the control group,there were statistically significant difference(all P < 0.05). Plasma levels of BNP and MCP-1 in IIIB group were higher than those in IIB group and IB group(all P < 0.05). The levels of BNP and MCP-1 were significantly higher in patients who had complex lesions compared with those who had simple lesions(P < 0.05). Multivariable logistic regression analysis revealed that BNP and MCP-1 were all risk factors for cardiac events(all P < 0.05). Conclusion:Measurement of BNP and MCP-1 are helpful in predicting the short-term prognosis in UA patients without heart failure.

    Reference
    Related
    Cited by
Get Citation

彭杰成,龙明智,章海燕,徐少华,姜〓海. BNP?MCP-1对不稳定型心绞痛近期预后判断的价值[J].南京医科大学学报(自然科学版英文版),2010,(3):405-408.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:
  • Revised:
  • Adopted:
  • Online:
  • Published:
Article QR Code